Effect of Ocimum sanctum (Tulsi) and vitamin E on biochemical parameters and retinopathy in streptozotocin induced diabetic rats

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 2, 2006, Pages 181-188

  Eshrat M , Halim ^a   Mukhopadhyay, A K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidants; Diabetes mellitus; Diabetic retinopathy; Lipid peroxidation; Ocimum sanctum; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LIPID PEROXIDASE; OCIMUM SANCTUM EXTRACT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GLUCOSE BLOOD LEVEL; LIPID ANALYSIS; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; RETINA EXAMINATION; STREPTOZOCIN DIABETES;

ANIMALIA; OCIMUM TENUIFLORUM;

EID: 33751115007     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02912939     Document Type: Article

References (36)

1. Robert, N. and Frank. (2004) Diabetic Retinopathy. New England Journal of Medicine 350, 48-58.
2. Klein, R. and Klein, B.E.K. (1995) Vision disorders in diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Bethesda, M D, NIH (Pub 1). 95 (1468), 293-338.
3. Rahi, J. S., Sripathi, S., Gilbert, C.E., Foster, A. (1995) Child hood blindness in India: Causes in 1318 blind school children in nine states. Eye 9, 545-550.
4. Riordan, E . P, Eye. (2003) In current Medical Diagnosis and Treatment. 42nd ed. Tierney L. M., Mcphee, S .J., Papadakis, M.A, Eds. (New York), Lange Medical Books / Mc Graw - Hill, 46, 177-1778.
5. Kumar, A. (1998) Diabetic blindness in India, The emerging scenario. Indian J Ophthalmol 46, 65- 69.
6. Harris, M.1, Hadden, W.C., Knowles, W.C. and Bennett, P.H. (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20 -74 yr. Diabetes 36, 523 -534.
7. U K Prospective. Diabetes Study Group. (1998) Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in- patients with type 2 diabetes (UKPDS33). Lancet 352, 837- 853.
8. Jain, S. K. (1999) Should high - dose vitamin E supplementation be recommended to patients? Diabetes Care 22, 8, 1242 -1244.
9. Sivaram, P. (1994) In New Developments in cardiology and cardiac surgery. Eds. Tehran, N., Kumar, A. Escort Heart Institute and Research Center, (New Delhi), 1.
10. Jain, S.K. (1996) The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids, suppl S. 86, 90-94
11. Eshrat, Halim M.A. Hussain, Kaiser Jamil and Mala Rao. (2001) Hypoglycemic, Hypolipidemic and antioxidant properties of Tulsi (Ocimum sanctum Linn) on streptozotocin induced diabetes in rats. Ind J Clin Biochem, 2, 190 -194.
12. Eshrat, H. M. (2002) Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian antidiabetic plant, Azadirachta indica (L.) Ind.J. Clin. Biochem 17, 115-123.
13. Eshrat, H. M. (2003) Lowering of blood sugar by water extract of Azadirachta indica and Abroma augusta in diabetes rats. Ind.J. Exp. Biol, 41,636 - 640.
14. Beers, R.F., Sizer, L.W. (1952) A spectro photometric method for measuring the break break down of hydrogen peroxide by catalase. J. Biol. Chem, 195,133.
15. Aeibi, H., Catalase. In., H.U., Berg, Meyer (ed). (1974) Methods in Enzymatic Analysis. Academic Press, New York, 673-684.
16. Saxena, A.K., Srivastava, P., Kale, R.K., Baqer, N.Z. (1993) Impaired antioxidant status in diabetic rat liver: Effect of vanadate. Biochem Pharmacol 45, 539-542.
17. Lawrence, R.A., Burk, R.F. (1976) Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 71, 952-958.
18. Gupta, D., Raju, J., Prakash, J., Baquer, N.Z. (1999) Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats; effect of a insulin and vanadate. Diabetes Res. Clin. Pract. 46, 1-7.
19. Halim, E. M. (2002) Hypoglycemic Hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma Longa, Linn and partially purified product from Abroma Augusta, Linn, in streptozotocin induced diabetes. Ind. J. Clin.Biochem. 17, 33-43.
20. Ohkawa, H., Ohishi, N. Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbioturic acid reaction. Analytical Biochemistry 95,351-358.
21. Lowry, W.H., Rosebrough, N.J., Farr A.L., Randall, R.J. (1951) Protein measurement with the Folin Phenol reagent. J Biol Chem 193, 265-275.
22. Friedewald W.T., Levy, R.I., and Fred Rickson , D.S. (1972) Estimation of the concentration of low - density Lipoprotein in cholesterol in plasma without use of the preparative a ultracentrifuge. Clin Chem. 18 (6), 499-500.
23. Hyvarinen, L, and Hochheimer, B. F. (1974) Filter systems in fluorescein angiography Int Ophthalmol Clin, 14 (3), 49-61.
24. Wilkinson, C.P. (1986) The clinical examination. Limitation and over utilization of Angiographic services. Ophthalmology, 93, 410-404.
25. Garg, M.C., Ojha ,S. and Bansal, D.D. (1996) Antioxidant status of streptozotocin diabetic rats, Ind. J. Exp. Biol, 34, 264-266.
26. Wolff, S. P., Dean, R. T. (1987) Glucose autoxidation and protein modification: The potential role of 'auto oxidative glycosylation' in diabetes, Biochem J, 245, 243-250.
27. The PKC-DRS Study Group* (2005) Initial Results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS). Multicenter Randomized Clinical Trial Diabetes, 54, 2188-2197
28. Cusick, M.,Chew, E.Y., Clemons, T.E., Klein, R., Klein, B.E.K. and Hubbard, L.D. (2002) Effect of antioxidant and Zinc supplements on development of diabetic retinopathy in the Age Related Eye Disease Study (AREDS). Invest Ophthalmol Vis Sci 43: E 1909.
29. Hammes, H. P., Xueliang Du, Edelstein, D, et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9, 294-299.
30. The Diabetes Control and Complications Trial Research Group. (1997) Clustering of Long -Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial. Diabetes 46: 1829-1839.
31. Sarkar, A., Lavania, S.C., Pandy, D.N., Pant , M.C. (1994) Changes in the blood lipid profile after administration of Ocimum sanctum (Tulsi) leaves in the normal albino rabbits Indian J Physiol Pharmacol, 38 (4), 311-2.
32. Baynes, J., Thorpe, S. (1999) Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48, 1-9.
33. Yanpallewar, S.U., Raj, S., Kumar, M., Achary, A. (2004) Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Biochem Behar 79(1), 155-164.
34. Sood, S., Narang, D., Dinda , A. K., Maulik, S. K. (2005) Chronic oral administration of Ocimum snctum Linn augments cardac endogenous antioxidants and prevents Isoproterenol induced myocardial necrosis in rats. J Pharm Pharmacol 57(1), 127-133.
35. Gupta, S.K., Srivastava, S., Trivedi, D Joshi, S., Halder, N. (2005) Ocimum sanctum modulates selenite - induced cataractogenic damage and prevents rat lens opacification. Curr Eye Res 30 (7), 583-591.
36. Geetha, R. K., Vasudevan, D.M. ( 2004) Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum : in vivo and in Vitro studies. Life Sci 76 (1), 21-28.